StartupOct 19, 2026Armed Cell Therapeutics Raises More Than €50 Million to Advance Next-Generation CAR-T TherapiesInvestment from India’s Mankind Pharma will support the development of next-generation cell therapies targeting lymphoma and small cell lung cancer.
StartupOct 19, 2026Armed Cell Therapeutics Raises More Than €50 Million to Advance Next-Generation CAR-T TherapiesInvestment from India’s Mankind Pharma will support the development of next-generation cell therapies targeting lymphoma and small cell lung cancer.
StartupOct 19, 2026Armed Cell Therapeutics Raises More Than €50 Million to Advance Next-Generation CAR-T TherapiesInvestment from India’s Mankind Pharma will support the development of next-generation cell therapies targeting lymphoma and small cell lung cancer.
StartupSpectaCell launches with €6 million to transform drug development and bring better immune therapies to patients faster
StartupSpectaCell launches with €6 million to transform drug development and bring better immune therapies to patients faster
StartupSpectaCell launches with €6 million to transform drug development and bring better immune therapies to patients faster
StartupRougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
StartupRougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
StartupRougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
StartupCatalyze Capital invests in Breye Therapeutics to advance pioneering oral treatments for retinal diseases
StartupCatalyze Capital invests in Breye Therapeutics to advance pioneering oral treatments for retinal diseases
StartupCatalyze Capital invests in Breye Therapeutics to advance pioneering oral treatments for retinal diseases
StartupAmyl Therapeutics haalt bijkomend € 8,25 miljoen op in Serie A-financieringsronde om baanbrekend platform voor neurodegeneratieve aandoeningen te valideren
StartupAmyl Therapeutics haalt bijkomend € 8,25 miljoen op in Serie A-financieringsronde om baanbrekend platform voor neurodegeneratieve aandoeningen te valideren
StartupAmyl Therapeutics haalt bijkomend € 8,25 miljoen op in Serie A-financieringsronde om baanbrekend platform voor neurodegeneratieve aandoeningen te valideren
IndustryFrom targeted quantification to in-depth characterization: Anabiotec expands its mass spectrometry capabilities
IndustryFrom targeted quantification to in-depth characterization: Anabiotec expands its mass spectrometry capabilities
OpinionCFO in Life Sciences: The Difference Between Financial Administration and Financial Leadership
OpinionCFO in Life Sciences: The Difference Between Financial Administration and Financial Leadership
IndustryFrom targeted quantification to in-depth characterization: Anabiotec expands its mass spectrometry capabilities
OpinionCFO in Life Sciences: The Difference Between Financial Administration and Financial Leadership
